Results 191 to 200 of about 3,741,108 (338)

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

Molecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo, Marco Siringo, Alessandro Vici, Ann Zeuner, Orietta Gandini, Paola Gazzaniga, Chiara Nicolazzo   +6 more
wiley   +1 more source

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis. [PDF]

BMC Gastroenterol
Liu HL, Liu X, Hu YF, Wang XX, Zhang Y, Wang L, Li SS, Bao YJ, Zheng SW, Xiong QF, Zhong YD, Liu DX, Huang P, Feng XN, Zeng WQ, Zhang CY, Zhang K, Yang YF.   +17 more
europepmc   +1 more source

GASTRIC DEVELOPMENT AND ANTIBODY TRANSFERENCE IN THE LAMB, WITH SOME OBSERVATIONS ON THE RAT AND GUINEA‐PIG

, 1956
K. J. Hill
openalex   +1 more source

Studies on the Mechanism of Inactivation of Human Complement by Plasmin and by Antigen-Antibody Aggregates [PDF]

, 1955
Irwin H. Lepow, Louis Pillemer, Leona Wurz   +2 more
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Sheet Protector Strategy for Western Blot to Reduce Antibody Consumption and Incubation Time. [PDF]

Biol Proced Online
Kwon S, Lee SY, Kim G.
europepmc   +1 more source

A FORMULATION OF THE SEROLOGICAL FLOCCULATION RATE IN THE REGION OF CONSIDERABLE ANTIBODY EXCESS [PDF]

, 1935
Sanford B. Hooker, William C. Boyd
openalex   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Nucleic acid-encoded antibody gene transfer-next generation of antibody therapies. [PDF]

Drug Deliv
Yu K, Xiao G, Chen B, Xu N, Liu W.
europepmc   +1 more source

Agglutinating Antibody Titers of Young White Leghorns and Rhode Island Reds Following Inoculation with Live and Inactivated Salmonella gallinarum Cultures

, 1959
Henry W. Garren, Charles H. Hill
openalex   +1 more source